Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
AstraZeneca
Moodys
McKesson
Julphar
Daiichi Sankyo
Cipla
Cerilliant
Farmers Insurance
Queensland Health

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 015193

« Back to Dashboard
NDA 015193 describes MESTINON, which is a drug marketed by Valeant Pharms Llc, Valeant Pharm Intl, and Valeant Pharms, and is included in four NDAs. It is available from two suppliers. Additional details are available on the MESTINON profile page.

The generic ingredient in MESTINON is pyridostigmine bromide. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

Summary for NDA: 015193

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 015193

Mechanism of ActionCholinesterase Inhibitors

Suppliers and Packaging for NDA: 015193

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESTINON
pyridostigmine bromide
SYRUP;ORAL 015193 NDA Valeant Pharmaceuticals North America LLC 0187-3012 0187-3012-20 473 mL in 1 BOTTLE (0187-3012-20)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength60MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Cantor Fitzgerald
Cerilliant
Deloitte
Baxter
US Department of Justice
Fuji
Mallinckrodt
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot